XML 19 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
OPERATING ACTIVITIES:    
Net income (loss) $ 5,456 $ (693)
Reconciliation of net income (loss) to net cash provided by operating activities:    
Depreciation, depletion and amortization 2,837 2,715
Deferred income taxes 199 159
Inventory valuation adjustments (168) 126
Non-cash compensation expense 81 93
Impairment losses 11 2,803
Equity Method Investment, Other than Temporary Impairment 0 129
Losses on extinguishments of debt (8) (62)
Distributions on unvested awards (19) (33)
Equity in earnings of unconsolidated affiliates (191) (46)
Distributions from unconsolidated affiliates 226 176
Other non-cash 13 (130)
Net change in operating assets and liabilities, net of effects of acquisitions 970 94
Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9,423 5,455
INVESTING ACTIVITIES:    
Capital expenditures, excluding allowance for equity funds used during construction (2,046) (4,030)
Contributions in aid of construction costs 29 61
Contributions to unconsolidated affiliate 4 37
Distributions from unconsolidated affiliates in excess of cumulative earnings 76 144
Proceeds from sales of other assets 38 10
Other 0 9
Net Cash Provided by (Used in) Investing Activities, Continuing Operations (1,907) (3,861)
FINANCING ACTIVITIES:    
Proceeds from borrowings 11,839 20,651
Repayments of debt (17,836) (20,293)
Proceeds from Issuance of Preferred Limited Partners Units 889 0
Subsidiary equity offerings, net of issue costs 0 1,580
Capital contributions from noncontrolling interest 114 203
Distributions to partners (1,383) (2,397)
Distributions to noncontrolling interests (1,149) (1,282)
Preferred Units, Cumulative Cash Distributions (37) (37)
Debt issuance costs (3) (53)
Other, net (4) 18
Net cash used in financing activities (7,570) (1,610)
Decrease in cash and cash equivalents (54) (16)
Cash and cash equivalents, beginning of period 367 291
Cash and cash equivalents, end of period $ 313 $ 275